Status:
COMPLETED
Alcohol Biomarkers in Post-Liver Transplant Patients
Lead Sponsor:
Northwestern University
Conditions:
Alcohol-related Liver Disease
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to compare the predictive validity and reliability of PEth testing at detecting alcohol use in post liver transplant patients. A prospective cohort study will be used to test ...
Detailed Description
Patients who have a positive PEth will be asked to have a confirmatory test performed 10-14 days after a positive result (PEth \>20ng/ml). The rationale for this procedure is to determine the test ret...
Eligibility Criteria
Inclusion
- men and women 18 years and over
- Participant must have received a liver transplant after January 1, 2003
- Participant must be six months or more post-transplant
- Mini-mental status score of greater than or equal to 20
- Participant must be well enough to participate in the research procedures over a 12 month period
- Participant must continue to be followed by the transplant center
Exclusion
- Individuals who do not consent
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT01812226
Start Date
March 1 2013
End Date
October 1 2015
Last Update
February 24 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611
2
University of Wisconsin, Madison
Madison, Wisconsin, United States, 53792